BRK-B vs MCI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
MCI presents a contradictory profile with a stable Piotroski F-Score of 6/9 and a Graham Number of $22.64, yet it is plagued by severe fundamental decay. While the balance sheet remains healthy with low debt (D/E 0.22), the company is experiencing a sharp contraction in both revenue (-20.70%) and earnings (-21.40%). Most critically, the 9.14% dividend is unsustainable with a payout ratio of 116.79%, indicating the company is returning more capital than it generates. The combination of negative growth and a 0/100 technical trend suggests a value trap scenario.
Compare Another Pair
Related Comparisons
BRK-B vs MCI: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Barings Corporate Investors (MCI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.